IP Verse

Amgen Research Munich patent opposition analysis

Get complete Patent Opposition Report for Amgen Research Munich

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest patents of Amgen Research Munich opposed by its competitors

Explore Amgen Research Munich's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3819007Jul 10, 2024Dosing Regimen For Anti-Bcma Agents2
EP2637670Mar 13, 2024Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains2
EP4058148Mar 13, 2024Dosing Regimen For Anti-Bcma Agents3
EP3531133Aug 23, 2023Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients1
EP3411402Dec 22, 2021Bcma And Cd3 Bispecific T Cell Engaging Antibody Constructs1
EP3228315Nov 25, 2020Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains2
EP3412687Mar 18, 2020Methods For Treating Dlbcl1
EP2780375Sep 11, 2019Binding Molecules For Bcma And Cd38
EP2780374Aug 21, 2019Binding Molecules For Bcma And Cd37
EP3149480Dec 26, 2018Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients1